Healthcare & Life Sciences
Healthcare and life sciences businesses operate inside systems where regulation, reimbursement, and clinical demand all shape performance. When the pressure hits margin, operations, or leadership, we bring the operating perspective these situations demand.
Complex Operations. High Stakes. The Operators Who Deliver Outcomes.
Healthcare and life sciences businesses don’t fail quietly. Reimbursement pressure, regulatory complexity, clinical labor constraints, and cost structures built for a different era all converge on the same place: operations. We’ve worked inside these businesses and know where margin is hiding, where compliance risk sits, and how to move without disrupting patient care or clinical quality.
- Hospitals & Health Systems
For-profit and non-profit hospitals, inner-city safety-net systems, and large multi-state systems — each with very different economics, and increasingly shifting to an employed-physician model. Our depth is in inner-city safety-net and non-profit turnarounds: labor model redesign, payer contract negotiation, and operational restructuring under reimbursement pressure.
- Physician Practice Management
Physician practice management groups, many now private equity-backed roll-ups. We help maximize the value of the services provided — driving billing and operational efficiency while managing risk across the practice.
- Senior Living & Care Communities
Senior living, assisted living, memory care, and hospice. Operators and CCRCs still working through COVID-era occupancy and balance-sheet distress, where operating discipline and capital structure have to be fixed together.
- Pharmaceutical
Small-cap and development-stage pharmaceutical companies navigating pipeline prioritization, capital allocation, runway management, and regulatory- or litigation-driven distress.
- Biotech
Development-stage biotech companies managing clinical milestones, manufacturing scale-up, and capital runway through clinical and commercial transitions.
- Medical Devices & Diagnostics
Operations, supply chain, and commercial strategy for device manufacturers and diagnostic platforms. Margin expansion, product portfolio rationalization, and post-acquisition integration.